-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 PlgNOewHwYGWMQl+KeW4B7qbDoiJqWJtuTtHIxz7NNpRAb+twhfYTXoMSGZqkpUS
 FuzXpk02+U15UUkp5a0+rw==

<SEC-DOCUMENT>0001477558-09-000004.txt : 20091231
<SEC-HEADER>0001477558-09-000004.hdr.sgml : 20091231
<ACCEPTANCE-DATETIME>20091231121342
ACCESSION NUMBER:		0001477558-09-000004
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20091230
FILED AS OF DATE:		20091231
DATE AS OF CHANGE:		20091231

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NeoStem, Inc.
		CENTRAL INDEX KEY:			0000320017
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				222343568
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		420 LEXINGTON AVENUE
		STREET 2:		SUITE 450
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170
		BUSINESS PHONE:		212-584-4171

	MAIL ADDRESS:	
		STREET 1:		420 LEXINGTON AVENUE
		STREET 2:		SUITE 450
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10170

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHASE III MEDICAL INC/DE
		DATE OF NAME CHANGE:	20030819

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNICHE GROUP INC /DE
		DATE OF NAME CHANGE:	19951117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FIDELITY MEDICAL INC
		DATE OF NAME CHANGE:	19951025

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Fullbright Finance Ltd
		CENTRAL INDEX KEY:			0001477766
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33650
		FILM NUMBER:		091267948

	BUSINESS ADDRESS:	
		STREET 1:		NO. 859, PANXU ROAD
		CITY:			SUZHOU
		STATE:			F4
		ZIP:			215002
		BUSINESS PHONE:		0086-512-68207173

	MAIL ADDRESS:	
		STREET 1:		NO. 859, PANXU ROAD
		CITY:			SUZHOU
		STATE:			F4
		ZIP:			215002
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0203</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2009-12-30</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000320017</issuerCik>
        <issuerName>NeoStem, Inc.</issuerName>
        <issuerTradingSymbol>NBS</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001477766</rptOwnerCik>
            <rptOwnerName>Fullbright Finance Ltd</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>NO. 859, PANXU ROAD</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>SUZHOU CITY, JIANGSU PROVINCE</rptOwnerCity>
            <rptOwnerState>F4</rptOwnerState>
            <rptOwnerZipCode>215002</rptOwnerZipCode>
            <rptOwnerStateDescription>CHINA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.001 per share</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>3047432</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Warrant</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.75</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2008-11-26</value>
            </exerciseDate>
            <expirationDate>
                <value>2013-11-25</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, par value $0.001 per share</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>400000</value>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Warrant (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2.5</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2009-10-29</value>
            </exerciseDate>
            <expirationDate>
                <value>2014-10-28</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock, par value $0.001 per share</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>640000</value>
                    <footnoteId id="F2"/>
                    <footnoteId id="F4"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Represents shares of common stock, par value $0.001 per share (&quot;Common Stock&quot;) of NeoStem, Inc. (the &quot;Company&quot;). This number of shares includes (1) 400,000 shares owned by the reporting person prior to the consummation of the merger (the &quot;Merger&quot;) of China Biopharmaceuticals Holdings, Inc., a Delaware corporation (&quot;CBH&quot;), with and into CBH Acquisition LLC, a wholly-owned subsidiary of the Company; (2) 640,000 shares issued upon the conversion of 64,000 shares of the Company's Series D Convertible Redeemable Preferred Stock on October 29, 2009; (3) 125,000 shares issued upon the consummation of the Merger; and (4) 1,882,432 shares agreed to be transferred to the reporting person by certain directors or officers of CBH upon consummation of the Merger, and the transfer of such shares were closed on December 30, 2009.</footnote>
        <footnote id="F2">The reporting person acquired 400,000 units in a November 28, 2008 private placement transaction with the Company (&quot;November 2008 Private Placement&quot;), with each unit consisting one share of Common Stock and on five-year warrant to purchase one share of Common Stock. The reporting person also acquired 64,000 shares of Series D Stock and warrants to purchase 640,000 shares of Common Stock in a June/July 2009 private placement transaction with the Company (&quot;June/July 2009 Private Placement&quot;). The units acquired in November 2008 Private Placement and the Series D Stock and warrants acquired in the June/July 2009 Private Placement were pledged to RimAsia Capital, L.P., and thereafter, to the Company and Suzhou Erye Pharmaceuticals Company, Ltd.</footnote>
        <footnote id="F3">Represents shares of Common Stock underlying warrants acquired by the reporting person in the November 2008 Private Placement.</footnote>
        <footnote id="F4">Represents shares of Common Stock underlying warrants acquired by the reporting person in the June/July 2009 Private Placement.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Mingsheng Shi, By: Kevin K. Tung, Esq., Attorney-in-Fact</signatureName>
        <signatureDate>2009-12-31</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----